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Acute administration of neuropeptideY (NPY) modulates alcoholintake in genetic and chemical models of high
intake, while leaving intake unaffected during ‘normal’or baseline conditions. In non-selected, normal rat lines,
alcohol consumption can be increased by prolonged exposure to alcohol, and it is unclear what effect a consti-
tutive increase in NPYfunctionwillhave on alcoholintake.The purpose of the present study was to examine the
effects on alcohol intake of an inducible, constitutive overexpression of NPY , one of the most abundant neuro-
peptides in the central nervous system. A liquid diet was used in combination with repeated alcohol deprivation
sessions to increase alcohol intake in normal Wistar rats.We then examined the effect of NPYoverexpression in
the amygdala on excessive alcohol intake produced by prolonged exposure to alcohol and alcohol deprivation.
Repeated withdrawal increased alcohol consumption in a 24-h continuous access two-bottle choice
model. Both the number of withdrawals as well as the length of the withdrawal periods affected alcohol
consumption with an increased intake resulting from multiple withdrawals and the alcohol deprivation effect
being enhanced by longer periods of abstinence. The increase in intake following repeated abstinence
was blunted by intra-amygdala administration of a Sindbis viral vector containing NPY cDNA. Amygdala
NPY overexpression also was demonstrated to be anxiolytic in the open field test. Repeated withdrawal in
combination with a history of alcohol consumption significantly elevated alcohol intake, and the amygdala may
mediate the transition to high-drinking states in this model.
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Introduction
Neuropeptide Y (NPY), a 36 amino acid peptide expressed
at high levels within the mammalian nervous system, has
been shown to have effects on emotional behaviour and
alcohol intake in rodent models. Nanomolar doses of NPY
injected centrally are anxiolytic in a number of animal
models of anxiety-related behaviour, including the elevated
plus-maze (Broqua et al., 1995), social interaction task
(Sajdyk et al., 1999), fear potentiated startle and condi-
tioned fear responses (Heilig et al., 1989, 1992; Broqua
et al., 1995; Tovote et al., 2004). In addition, intracer-
ebroventricular (i.c.v.) administration of NPY prevents
gastric ulceration induced by water restraint, a strong
stressor (Heilig and Murison, 1987). Transgenic rats
overexpressing NPY in the hippocampus were shown to
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 be resistant to stress-induced increases in anxiety-like
behaviour (Thorsell et al., 2000; Carvajal et al., 2004).
These studies indicate that activation of NPY signalling
attenuates stress-related effects.
NPY also has been demonstrated to have a role in the
regulation of alcohol intake, dependence and withdrawal.
The effect profile of NPY shows numerous similarities with
that of established anti-anxiety compounds and also that
of alcohol. A direct link between NPY signalling and
regulation of alcohol consumption was first shown in a
study where mice with a null-mutation in the NPY gene
demonstrated increased alcohol consumption, while mice
with a transgenic overexpression of NPY consumed less
alcohol (Thiele et al., 1998). The effect of NPY on alcohol
consumption appears to be in part dependent on the
individual’s history and state of alcohol consumption. In
animal studies, central administration of NPY into the
lateral ventricles, central nucleus of the amygdala or the
third ventricle leaves levels of alcohol intake unaffected in
normal, outbred rat strains (Badia-Elder et al., 2001; Katner
et al., 2002a, b). However, a significant suppression of
alcohol intake can be seen in the high-drinking alcohol-
preferring P line of rats compared to non-preferring NP and
normal Wistar rats, and in the high alcohol drinking (HAD)
rat line (Badia-Elder et al., 2001, 2003). Further evidence for
NPY’s involvement in the regulation of alcohol intake comes
from a study using animals in which dependence and high
alcohol preference were induced using 8-week exposure to
intermittent alcohol vapour (14h on/10h off per day; target
blood alcohol level 200mg%). Intermittent alcohol exposure
models chronic alcohol consumption and produces beha-
vioural changes similar to clinical manifestations as well as
long-term changes in neurochemistry and increases in alcohol
intake(Rimondinietal.,2002).Inthismodel,NPYwasshown
to significantly suppress alcohol intake in exposed animals
compared to saline treatment. Notably, consumption was
reduced back to, but not below, pre-vapour exposure levels
(Thorsell et al., 2005).
The efficacy of NPY to suppress alcohol intake in the
preferring lines which consume alcohol for its pharmaco-
logical properties, and the non-efficacy of NPY in states of
low intake, are important in understanding a basic
distinction in the mechanisms of alcohol intake. A basal
component of alcohol consumption is unrelated to the
pharmacological/rewarding properties of alcohol, but is
related to its properties as a caloric nutrient and can be
regulated by factors modulating appetite. This component
is not suppressed by NPY—it is stimulated by hypothalamic
NPY injections, as would be expected from the well-
established property of NPY to stimulate appetite (Kelley
et al., 2001). A further illustration of the changes in
neurobiology induced by a history of alcohol exposure/
intake is the observation that suppression of alcohol
consumption by i.c.v. administration of an NPY Y2
receptor antagonist, while present in the non-exposed
animal, is strongly facilitated in animals with a history of
alcohol exposure, indicating sensitization to the effect of
the antagonist in these animals (Thorsell et al., 2002;
Rimondini et al., 2005).
The different facets of alcohol-related behaviour can be
examined using different animal models. The alcohol
deprivation effect (ADE), defined as a temporary increase
in absolute alcohol intake and in the ratio of alcohol intake/
total fluid intake seen when access to alcohol is reinstated
after a period of abstinence, has been suggested to model
alcohol craving (Sinclair and Li, 1989; Heyser et al., 1997).
The ADE has been used to test pharmacological strategies
to prevent relapse to alcohol intake (Spanagel and
Zieglgansberger, 1997; Heyser et al., 1998) and has been
demonstrated in a number of species, including rats (Rodd-
Henricks et al., 2000a, b), mice (Salimov and Salimova,
1993), monkeys (Kornet et al., 1990a) and humans (Burish
et al., 1981).
The amygdala has been the most prominent region of
interest with regard to emotionality. The central nucleus of
the amygdala was initially suggested to be the mediating site
of anxiolytic NPY actions (Heilig et al., 1993), as well as the
lateral/basolateral complex (Sajdyk et al., 1999).
Furthermore, in clinical studies of alcohol dependence, a
correlation between initial anxiety and subsequent alcohol
abuse, possibly due to the anxiolytic action of alcohol, has
been demonstrated (Pandey, 2003; Pandey et al., 2003).
While this may only be true for a subgroup of alcoholics, it
may partially explain some of the changes and effects seen
for NPY in alcoholism.
Previous work has involved only the acute administration
of NPY, and it is unknown whether a constitutive change in
NPY in the amygdala will convey similar effects.
Overexpression in the central nervous system can be
accomplished using viral vectors. Viral vectors derived
from Sindbis and the related Semliki Forest virus—
members of the family of alpha-viruses—have been
extensively used to transduce post-mitotic neurons (Xiong
et al., 1989; Ehrengruber et al., 1999). Sindbis selectively
infects neurons and confers a rapid onset and high level of
expression of foreign genes. For the present study, we used
a vector derived from a Sindbis virus mutant in which a
single change in the viral nsP2 protein from proline to
serine inhibits virus-induced suppression of host RNA
synthesis that otherwise occurs with Sindbis virus. The
decreased suppression of host RNA synthesis is interestingly
accompanied by higher levels of expression of a reporter
gene (Dryga et al., 1997).
The hypothesis that constitutive changes in NPY activity
may mediate the increased alcohol consumption associated
with forced exposure and repeated alcohol deprivations
was tested. A 24h two-bottle free choice paradigm was
used with administration of a Sindbis viral vector to
induce localized overexpression of NPY within the central
nucleus of the amygdala. To examine anxiety-related
behaviour in these animals, behaviour in the open field
also was tested.
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 Material and methods
Animals
Male Wistar rats (220–240g at start of experiment; n¼16)
were used. Animals were kept single-caged throughout the
study with food and water available ad libitum except
during the liquid diet. Animals were housed in a 12 : 12h
light/dark cycle. All procedures were conducted in strict
adherence to the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committee of The
Scripps Research Institute.
Viral vector procedures
Host shut-off deficient Sindbis virus vector was obtained
from Dr Andreas Jeromin (Jeromin et al., 2003). With this
system, separate transcripts are co-transfected by electro-
poration into Baby Hamster Kidney (BHK) cells—one
containing the genomic RNA coding for the replicase and
gene(s) of interests, and the other containing structural
proteins. The NPY propeptide and green fluorescent
protein (GFP) were co-expressed through double subge-
nomic promoters (Okada et al., 2001). Virus expressing
GFP only from an identical vector was used for control.
Sindbis structural proteins expressed on a separate vector
and the vector expressing non-structural proteins and the
proteins of interest (both NPY and GFP, or GFP alone)
were transcribed using in vitro transcription with SP6 RNA
polymerase and co-transfected by electroporation into
BHK-21 cells for virion production. Virions were harvested
4 days later and concentrated by ultracentrifugation at
120000 g at 4 C for 3h to obtain a titre of 10
10
transducing virions per millilitre.
Alcohol two-bottle choice
Alcohol two-bottle choice was performed as previously
described (Moller et al., 1997). Briefly, single-housed
animals were given a choice between a bottle containing
water with decreasing concentrations of saccharin and a
bottle with decreasing concentrations of saccharin
and increasing concentrations of alcohol. The end
concentrations of each were 0% saccharin and 10% (w/v)
ethanol. The bottles were shifted side to side during the
experiment to avoid biased results due to side preference.
The bottles were weighed daily, and the amount of
consumed alcohol in g/kg body weight was determined.
Preference for the alcohol solution also was calculated.
Alcohol deprivation schedule
Animals were repeatedly deprived of alcohol in this study
(Fig. 1). The first deprivation was performed at around
10 weeks of ‘alcohol history’. The 12 weeks (the first
deprivation occurred in week 10, but the drinking
continued for another 2 weeks) consisted of an initial
4-week baseline of two-bottle free choice drinking followed
by 4 weeks of liquid diet, and then another 4-week session
of two-bottle free choice. The deprivations were for 72h
(Friday morning to Monday morning) except when longer
time-intervals are indicated (Table 1). The initial depriva-
tion was for 72h followed by 2 weeks of alcohol access and
Fig.1 Outline of the deprivation schedule prior to viral vector treatment. All 72h deprivations took place Friday^Monday, and the longer
deprivation periods were initiated Friday of the preceding week.
Table 1 Alcohol intake and preference during repeated
deprivations prior to viral vector treatment
Week
of study
Alcohol
deprivation
effect
(g/kg/24h)
Alcohol
deprivation
effect
(% preference)
Intake
during
days 2^4
(g/kg/24 h)
Deprivation
period
10 1.4   0.1 58   41 . 1 3  0.2 72 h
14 2.1  0.2 61  5.5 1.43  0.12 2 weeks
15 1.6  0.3 55  3.3 1.3  0.15 72 h
29 5.2 0.6 74   62 . 5  0.2 13 weeks
30 3.2 0.4 54  52 . 1  0.34 72h
31 3.3  0.3 57  62 . 4   0.3 72 h
32 3.8  0.5 52  62 . 8   0.21 72 h
33 3.4  0.5 54  52 . 7  0.16 72 h
35 3.6  0.4 75  42 . 7  0.17 2 weeks
36 5.4  0.6 62  63 . 1  0.16 72 h
37 3.9  0.4 67  52 . 8   0.23 72h
38 4.1 0.4 66   42 . 9   0.17 72 h
39 3.8  0.4 69  32 . 8   0.13 72 h
40 3.8  0.3 64  53 . 2  0.13 72 h
41 4.5  0.4 71  43 . 5  0.2 72 h
The deprivation schedule was as pictured in Fig.1.
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 then a 2-week deprivation period. Following this 2-week
deprivation, drinking was reestablished, and another 72h
deprivation was performed. A long (13 weeks) deprivation
followed. Following the extended deprivation, seven short
(72h) deprivations were done prior to the next 2-week
deprivation. After the 2-week deprivation, drinking baseline
was reestablished for 3 weeks, and animals were selected
for surgery. Following surgery and recovery, 5 weeks of
drinking studies were done that included four deprivation
sessions. After the last drinking measure, animals were
taken off of the alcohol and allowed a 1-week period of
abstinence prior to examination of anxiety-related behav-
iour in the open field.
Alcohol liquid diet
To induce a history of dependence in the animals, an
alcohol liquid-diet was used. The diet was maintained for
4 weeks, and during this time no additional food or water
was available to the animals. The diet was prepared by
mixing ‘Boost’ with vitamins and minerals and ethanol to
yield a 10% v/v solution. The liquid was checked and
changed on a daily basis, and the animals were weighed to
detect any weight-loss due to the diet.
The open field test
Anxiety/activity testing was done using an open field. The
animal was allowed to explore an open surface (1 1m
2;
divided into 25 squares) freely for 10min. The amount
of time spent in the nine central squares, the four corner
squares and the 16 peripheral squares was measured as was
the number of line-crossings made within the entire field
and within each subset of squares. The open field was
performed under red light conditions during the animals’
active phase. Behaviour was observed by an individual blind
to treatment condition.
Surgery
Animals were anaesthetized using isoflurane, and Sindbis
viral vector (control GFP or NPY) was injected using a
microsyringe into the central nucleus of the amygdala
(AP:  2.1mm, L:  4.6mm, VD:  8.7mm) (Paxinos and
Watson, 1997). GFP expression was used to validate vector
expression of both NPY and control vector-injected
animals; the NPY-expressing vector also expressed GFP.
Injection accuracy was verified by GFP expression in a
separate set of control animals. Cannula placement could
not be determined in the experimental animals because of
the disappearance of injection tracts due to the long time
which had elapsed since the injection, which extended past
the duration of GFP expression. In the present study,
the behavioural response of the animals in the open field
was used as an index of a successful injection. Great care
was taken not to induce any lesions.
Following surgery, animals were allowed a 1-week
recovery prior to restarting the two-bottle free choice and
anxiety/activity testing.
Statistics
Statistical analyses were performed using STATISTICA 7.0
software. A repeated-measures ANOVA was used for the
drinking data followed by Tukey’s HSD post hoc test when
appropriate. The open field data were analysed using the
t-test for independent samples.
Results
Viral vector construct
Transduction of NPY- and GFP-transducing Sindbis viral
vector deficiency in the host shut-off function is shown in
Fig. 2. Expression was robust in central amygdala neurons
and quite protracted as expected from previous applications
of this vector (Jeromin et al., 2003). The injection was
Fig. 2 (A) Detection of green fluorescent protein (GFP)/NPY-expressing neurons in the central nucleus of the amygdala1week after
injection with a high titre Sindbis viral vector by GFP fluorescence (neurons and fibres are seen at10  magnification).The vector used is
deficient in viral-induced shut-off of protein synthesis of the infected cell resulting in protracted expression and apparent lack of toxicity
without compromising expression levels of the transduced genes (Jeromin et al.,2 0 0 3 ) .( B) Higher magnification of GFP/NPY-expressing
neurons and fibres (at 40  magnification). (C) Expression remained robust 2 weeks after infection and (D) was still detectable 4 weeks
after infection. (E) Co-detection of GFP and (F) NPY in primary neurons infected with the GFP/NPY-expressing Sindbis vector.
Scale bar¼100 mmi nA,2 5mmi nB, E,F,a n d2 0 0mmi nC, D.
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 highly localized. High magnification pictures are shown
because of the small size of the neurons and to demonstrate
immunoreactive fibres. Tissue was not fixed to limit
quenching of GFP by fixative; therefore, additional pictures
could not be taken. As mentioned earlier, the injection site
could not be verified in the experimental rats because of the
long duration of the experiment and the disappearance of
the injection tracts. One animal was excluded from the data
analysis because of a failure to observe an anxiolytic-like
effect in the open field.
Baseline alcohol intake: effect of
liquid diet on intake
Baseline intake of alcohol and preference for the alcohol
solution are shown in Table 1. The baseline intake prior to
animal exposure to the liquid diet was 1.1 0.2g/kg/24h.
Following the liquid diet during which animals consumed
on average 11.4 0.7g/kg/24h of pure ethanol, the
consumption was slightly, but not significantly, elevated
to 1.53g/kg/24h.
Alcohol deprivation effect and alcohol intake
The ADE was defined as consumption during the first 24h
following a deprivation period. Data are shown in Table 1.
The initial 72h deprivation did not significantly elevate
ADE-induced intake. A longer deprivation time, 2 weeks,
significantly elevated intake on day 1 compared to baseline
while leaving drinking on day 2–4 unaffected. The 13-week
deprivation led to an increase from 1.5 0.2 to 5.2 0.6g/
kg/24h. The day 2–4 intake following 72h deprivation
slowly increased and had, after the last deprivation,
increased by 132 8.5% (P50.001) and 310 14%
(P50.0001) compared to post-13-week deprivation and
initial intake baseline, respectively.
Effect of amygdala NPYoverexpression on
alcohol intake, water intake and body weight
Overexpression of NPY in the amygdala significantly
decreased alcohol intake starting at day 13 post-surgery
[Fig. 3; overall treatment day interaction:
F(25,225)¼3.03, P50.00001] while leaving water intake
unaffected [Table 2; F(25,225)¼0.02, P¼1.0].
Overexpression of NPY in the amygdala did not signifi-
cantly affect body weight development in treated animals
compared to controls [Table 2; F(25,225)¼0.13, P¼0.98].
Effect of amygdala NPYoverexpression on
open field behaviour
Amygdala NPY overexpression did not significantly affect
latency to reach the perimeter of the open field, though
there was a trend toward increased latency in the NPY-
treated animals (Fig. 4). The amount of time spent in the
centre of the open field was significantly increased, and the
time spent in the corners of the maze was significantly
decreased (P50.001 and P50.01, respectively; t-test for
independent samples), indicating an anxiolytic-like effect of
the viral vector overexpression.
Effect of amygdala NPYoverexpression on
general behaviour
The novel Sindbis viral vector did not induce any visible
aversive side-effects as determined by a general assessment
of the animals’ health and physical appearance. Subjects
treated with control vector and animals treated with the
NPY-containing construct recovered well from surgery and
had normal appearance (fur, eye colour, body posture,
etc.), weight gain and locomotor skills.
Discussion
We have demonstrated that repeated alcohol deprivation
periods increased subsequent alcohol intake measured both
Fig. 3 Effect of Sindbis viral vector-mediated overexpression of
NPYin the amygdala on alcohol consumption during baseline and
alcohol deprivation effect. Animals were injected on day 0, and
two-bottle free choice drinking was initiated directly after surgery.
Treatment significantly suppressed drinking from day 13 onward.
*P50.05, **P50.01 and ***P50.001.
Table 2 Water intake and body-weight development
following intra-amygdala administration of viral vector
[control (GFP) or NPY]
Time Controls NPY
Water intake (ml) Pre-surgery 13.6 1.2 14.2  1.1
Post-surgery measure 1 14.9 1.1 13.2  1.1
Post-surgery measure 10 13.2  2.0 14.7 2.1
Post-surgery measure 20 13.6 1.7 12.9 1.3
Post-surgery last measure 14.3 1.2 14.1  1.2
Body weight (g) Pre-surgery 761 4.5 758   4.4
Post-surgery measure 1 771  4.5 773 3.5
Post-surgery last measure 768 3.0 765  3.5
Viral vector treatment did not significantly affect either water
intake or body weight.
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 as ADE and post-ADE alcohol intake when alcohol was
presented after a history of dependence induction.
Furthermore, we showed that overexpression of NPY locally
in the central nucleus of the amygdala significantly reduced
the elevated alcohol consumption induced by a prolonged
history of alcohol consumption and deprivation cycles.
The NPY system may be a particularly interesting target
system involved in the development of alcohol dependence
as well as mood disorders such as depression and anxiety
syndromes. NPY is an endogenous anxiolytic compound. It
functions as an antidepressant and is effective in modifying
alcohol intake in high-drinking states. Evidence indicating
an involvement of NPY in the modulation of neurobiolo-
gical responses to alcohol and in regulation of alcohol
intake stems from the observation that NPY expression
levels are inversely related to alcohol intake in mice (Thiele
et al., 1998). In addition, a number of genetic mapping
studies in animals bred for high and low alcohol preference/
consumption reveal significant differences in NPY and NPY
receptor expression patterns (Ehlers et al., 1998; Hwang
et al., 1999; Caberlotto et al., 2001; Murphy et al., 2002).
Low NPY signalling in animal models correlates with high
alcohol drinking in alcohol-preferring P rats and high-
alcohol-drinking HAD rats, which have low levels of NPY
in the amygdala compared to controls (Ehlers et al., 1998;
Hwang et al., 1999). Furthermore, administration of alcohol
and alcohol withdrawal alter central NPY expression and
levels (Clark et al., 1998; Ehlers et al., 1998; Roy and
Pandey, 2002). In addition, i.c.v. administration of NPY
reduces alcohol drinking in alcohol-preferring P rats
(Badia-Elder et al., 2001) as well as in rats with a history
of alcohol vapour exposure (Thorsell et al., 2005).
In the present study, we induced a state of high intake by
repeated alcohol deprivations and reexposures to alcohol.
The fact that the intake levels and/or the resulting blood-
alcohol levels were not as high as those seen during alcohol
vapour exposure does not detract from the importance of
the demonstrated dramatic increase in alcohol intake and
the effects produced by a constitutive increase in NPY
expression on both ADE amplitude and intake during post-
ADE days 2–4. These results demonstrate that a long period
of moderate-to-high intake in combination with repeated
deprivations may induce behavioural changes similar to
those seen after exposure to models inducing significantly
higher blood alcohol levels. Furthermore, a suppression of
intake in this prolonged intake model by constitutive NPY
overexpression demonstrates that there may be underlying
changes in neuronal processes (as well as at the molecular
level) that are similar to more ‘extreme’ methods of
inducing a high intake state.
The anxiolytic effects of NPY are in part mediated
through the amygdala. Thus, it has been hypothesized that
Fig. 4 Effect of Sindbis viral vector-mediated overexpression of NPYin the amygdala on anxiety-related behaviour in the open field.
(A) Total activity measured as number of lines crossed in the open field. (B) Latency for animals to reach the perimeter of the open
field upon introduction into the apparatus. (C) Presence of animals in centre squares of the open field. (D)P r e s e n c eo fa n i m a l s
in the corners of the open field. *P50.01and **P50.001.
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 increased levels of NPY in this region lead to a reduction
in anxiety-related behaviour and may lead to a reduction in
alcohol intake in high-drinking states. Previous studies in
animals without a history of alcohol exposure/high intake
showed no effect of NPY on alcohol intake (Katner et al.,
2002a). However, the amygdala has been demonstrated
numerous times to be a site of action for the anxiolytic
actions of NPY (Heilig, 1995). The anxiety induced by
repeated withdrawal cycles may indeed be directly attenu-
ated by NPY and/or NPY may substitute for ethanol’s acute
anti-anxiety effect and by this lead to decreased intake.
Other non-benzodiazepine drugs have been shown to
indeed also affect alcohol withdrawal and relapse to alcohol
intake, for example gabapentin, vigabatrin and topiramate
(Book and Myrick, 2005).
In the present study, the hypothesis that a constitutive
increase in amygdala NPY would alter increased drinking in
response to alcohol deprivation was tested. Alcohol intake
was the primary measure, and anxiety-related behaviour in
the open field also was tested.
The ADE has been suggested to be an animal model of
human relapse. Relapse behaviour for individuals with a
history of alcohol abuse or alcoholism is a substantial
problem. Approximately 60–80% of abstinent alcoholics
will relapse during their lifetime. A number of criteria for
relapse exist, but the primary criterion suggests that an
increase in intake, or at least consumption at pre-abstinence
levels, constitutes a relapse. The ADE is defined as a
temporary increase in alcohol intake and in the preference
for the alcohol solution over other solution(s) present
upon reinstatement of alcohol following a period of
deprivation. The ADE is present after both short (12h or
less) (Sinclair and Li, 1989) and long (up to 75 days)
(Sinclair et al., 1973) periods of abstinence and thus is not
a result of acute physiological withdrawal. In addition,
while the ADE does occur in animals with a short history of
alcohol consumption not sufficient to result in physical
dependence, the amplitude of the ADE may be increased in
animals with a history of physical dependence (Rodd-
Henricks et al., 2000a, b). The magnitude of the ADE also
may be correlated with the length of the abstinence period
(Kornet et al., 1990b; Heyser et al., 1997). In outbred rats,
the ADE has been examined using both 24h free choice
drinking and operant self-administration (Wolffgramm and
Heyne, 1995; Roberts et al., 2000). The ADE may be used as
a measure of increases in alcohol intake and/or preference
in rodent models of alcohol consumption.
The ADE has been demonstrated in numerous studies
using both outbred animals as well as animals bred for high
alcohol consumption. Using outbred rats, an increase
in alcohol intake from a ‘controlled’ level to a ‘high’ level
(2–3.5g/kg/day; thought to reflect ‘loss of control’ or an
‘addicted state’) has been demonstrated (Wolffgramm and
Heyne, 1995). However, it is a concern that these ‘high’
levels of intake may not be indeed ‘high’ but rather should
be defined as ‘moderate’. We demonstrated that it is
possible to increase the ADE to levels almost twice that are
defined here as ‘high’. In the present paradigm, where the
animals had a history of dependence, a longer deprivation
session elevated ADE-induced drinking to over 5g/kg/day, a
level of intake similar to that seen in some of the selectively
bred high consumption lines as well as the intake level seen
following cyclic exposure to alcohol vapour. While the level
of intake seen during the ADE did not persist during the
following days of alcohol intake (days 2–4 in this study),
the level of intake during these days slowly elevated with
the number of deprivation cycles and reached a stable level
of around 3–3.5g/kg/day, a level significantly higher than
the original baseline intake of 1.13g/kg/day.
In summary, prolonged moderate alcohol intake devel-
oped into high intake when combined with repeated
deprivation periods and a history of dependence. Local
constitutive NPY overexpression in the amygdala blunted
this increase. These results provide further support for NPY
dysregulation as a mediator of excessive drinking in alcohol
abuse and alcoholism.
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